Correction to: Scientific Reports 10.1038/s41598-021-91449-z, published online 04 June 2021
The original version of this Article contained errors in Table 3, where some values in Number of deaths were incorrectly given. The original Table 3 and accompanying legend appear below.
Table 3.
Univariate and multivariate analyses of factors associated with overall survival.
| Factor | Number of deaths | Univariate analysis | Multivariate analysis | Hazard ratio | |
|---|---|---|---|---|---|
| p-value | p-value | (95% CI) | |||
| Sex | F | 04-Sep | 0.3 | NE | – |
| M | 32/51 | ||||
| Age (years) | < 66 | 16/28 | 0.6 | NE | – |
| ≥ 66 | 20/32 | ||||
| T Stage | X, 1–2 | Oct-22 | 0.2 | NE | – |
| 3–4 | 26/38 | ||||
| N Stage | 0–1 | 03-Aug | 0.4 | NE | – |
| 2–3 | 33/52 | ||||
| Clinical stage | IIIA | Jun-16 | 0.3 | NE | – |
| IIIB | 22/32 | ||||
| IIIC | 08-Dec | ||||
| Histology | Adenocarcinoma | 16/26 | 0.5 | NE | – |
| Others | 20/34 | ||||
| Smoking historya | Never/former | 21/36 | 0.9 | NE | – |
| Current | 13/22 | ||||
| ECOG-PSa | 0 | Aug-21 | 0.004 | 0.011 | 2.91 |
| 1 | 25/36 | (1.28–6.64) | |||
| Laterality | Right | 17/31 | 0.5 | NE | – |
| Left | 18/26 | ||||
| Lobe | Upper/middle | 28/49 | 0.2 | NE | – |
| Lower | 08-Nov | ||||
| FEV1 (l)a | < 2.2 | 17/29 | 0.2 | NE | – |
| ≥ 2.2 | 13/22 | ||||
| Chemotherapy | Standard | 29/49 | 0.5 | NE | – |
| Reduced | 07-Nov | ||||
| BMIa | F: < 17, M: < 25 | 28/41 | 0.03 | NE | – |
| F: ≥ 17, M: ≥ 25 | Jul-18 | ||||
| SMI | F: < 24, M: < 43 | 17/22 | 0.01 | 0.02 | 2.36 |
| F: ≥ 24, M: ≥ 43 | 19/38 | (1.15–4.85) | |||
| PMI | F: < 4.7, M: < 7.3 | 31/52 | 0.4 | NE | – |
| F: ≥ 4.7, M: ≥ 7.3 | 05-Aug | ||||
| MA | F: < 9, M: < 36 | 15/24 | > 0.99 | NE | – |
| F: ≥ 9, M: ≥ 36 | 21/36 | ||||
| VAI | F: < 97, M: < 40 | 28/42 | 0.1 | NE | – |
| F: ≥ 97, M: ≥ 40 | Aug-18 | ||||
| SAI | F: < 127, M: < 28 | 23/34 | 0.09 | NE | – |
| F: ≥ 127, M: ≥ 28 | 13/26 | ||||
| VSR | F: < 0.8, M: < 0.6 | Aug-19 | 0.1 | NE | – |
| F: ≥ 0.8, M: ≥ 0.6 | 28/41 |
NE not entered, ECOG-PS Eastern Cooperative Oncology Group performance status, FEV1 forced expiratory volume in 1 s, BMI body mass index, MA mean muscle attenuation, SMI skeletal mass muscle index, PMI psoas muscle index, VAI visceral adiposity index, SAI subcutaneous adiposity index, VSR visceral-to-subcutaneous fat ratio, CI confidence interval.
aThese variables have missing values.
The original Article has been corrected.